Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

VolitionRX Q3 EPS $(0.05) Misses $(0.04) Estimate, Sales $627.277K Miss $1.681M Estimate

Author: Benzinga Newsdesk | November 13, 2025 04:25pm
VolitionRX (AMEX:VNRX) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 13.64 percent. This is a 28.57 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $627.277 thousand which missed the analyst consensus estimate of $1.681 million by 62.68 percent. This is a 32.19 percent increase over sales of $474.522 thousand the same period last year.

Posted In: VNRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist